166 related articles for article (PubMed ID: 35459781)
21. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
22. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T
J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514
[TBL] [Abstract][Full Text] [Related]
23. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
24. MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
You Y; Tan JX; Dai HS; Chen HW; Xu XJ; Yang AG; Zhang YJ; Bai LH; Bie P
Oncotarget; 2016 Aug; 7(35):57099-57116. PubMed ID: 27494859
[TBL] [Abstract][Full Text] [Related]
25. Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.
Wang C; Shang C; Gai X; Song T; Han S; Liu Q; Zheng X
Front Cell Dev Biol; 2021; 9():631931. PubMed ID: 33889573
[TBL] [Abstract][Full Text] [Related]
26. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
28. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
29. Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells.
Wu MH; Chen YL; Lee KH; Chang CC; Cheng TM; Wu SY; Tu CC; Tsui WL
Sci Rep; 2017 Sep; 7(1):11006. PubMed ID: 28887481
[TBL] [Abstract][Full Text] [Related]
30. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.
Lau EY; Lo J; Cheng BY; Ma MK; Lee JM; Ng JK; Chai S; Lin CH; Tsang SY; Ma S; Ng IO; Lee TK
Cell Rep; 2016 May; 15(6):1175-89. PubMed ID: 27134167
[TBL] [Abstract][Full Text] [Related]
31. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.
Leung Z; Ko FCF; Tey SK; Kwong EML; Mao X; Liu BHM; Ma APY; Fung YME; Che CM; Wong DKH; Lai CL; Ng IO; Yam JWP
J Exp Clin Cancer Res; 2019 Oct; 38(1):423. PubMed ID: 31640796
[TBL] [Abstract][Full Text] [Related]
32. Cancer-associated fibroblasts in hepatocellular carcinoma.
Kubo N; Araki K; Kuwano H; Shirabe K
World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming.
Wang H; Liu F; Wu X; Zhu G; Tang Z; Qu W; Zhao Q; Huang R; Tian M; Fang Y; Jiang X; Tao C; Gao J; Liu W; Zhou J; Fan J; Wu D; Shi Y
Exp Cell Res; 2024 Feb; 435(2):113947. PubMed ID: 38301989
[TBL] [Abstract][Full Text] [Related]
34. Tumor-Stroma Crosstalk Enhances REG3A Expressions that Drive the Progression of Hepatocellular Carcinoma.
Cho Y; Park MJ; Kim K; Park JY; Kim J; Kim W; Yoon JH
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940813
[TBL] [Abstract][Full Text] [Related]
35. Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma.
Kato K; Fukai M; Hatanaka KC; Takasawa A; Aoyama T; Hayasaka T; Matsuno Y; Kamiyama T; Hatanaka Y; Taketomi A
Ann Surg Oncol; 2022 Oct; 29(11):7135-7146. PubMed ID: 35543908
[TBL] [Abstract][Full Text] [Related]
36. Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68.
Yamanaka T; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Hagiwara K; Gantumur D; Handa T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Umezawa K; Shirabe K
Mol Cancer Ther; 2021 Jun; 20(6):1019-1028. PubMed ID: 33722852
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract][Full Text] [Related]
38. Reprogramming of cancer-associated fibroblasts by apoptotic cancer cells inhibits lung metastasis via Notch1-WISP-1 signaling.
Kim HJ; Yang K; Kim K; Lee YJ; Lee S; Ahn SY; Ahn YH; Kang JL
Cell Mol Immunol; 2022 Dec; 19(12):1373-1391. PubMed ID: 36241874
[TBL] [Abstract][Full Text] [Related]
39. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
Mazzocca A; Dituri F; Lupo L; Quaranta M; Antonaci S; Giannelli G
Hepatology; 2011 Sep; 54(3):920-30. PubMed ID: 21674557
[TBL] [Abstract][Full Text] [Related]
40. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
